Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).

Source:http://linkedlifedata.com/resource/pubmed/id/17102115

Download in:

View as

General Info

PMID
17102115